FRESENIUS KABI (THAILAND) LTD., — Gemcitabine Importer Profile
Pharmaceutical Importer · #14 buyer for Gemcitabine · $630.4K import value · 21 shipments · THAILAND · DGFT Verified
FRESENIUS KABI (THAILAND) LTD., is the #14 importer of Gemcitabine from India with $630.4K in import value and 21 verified shipments. FRESENIUS KABI (THAILAND) LTD., holds a 1.5% market share in Gemcitabine imports based in THAILAND. The company sources from 1 verified supplier across 16 formulations shipped to 1 country. Overall, FRESENIUS KABI (THAILAND) LTD., imports 7 pharmaceutical products worth $5.0M across 2 therapeutic categories.
FRESENIUS KABI (THAILAND) LTD., — Gemcitabine Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Gemcitabine to FRESENIUS KABI (THAILAND) LTD.,?
Verified from 21 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| FRESENIUS KABI ONCOLOGY LIMITED | $630.4K | 21 | 100.0% |
FRESENIUS KABI (THAILAND) LTD., sources Gemcitabine from 1 verified Indian supplier based on 21 customs records. The primary supplier is FRESENIUS KABI ONCOLOGY LIMITED accounting for 100.0% of imports.
How Does FRESENIUS KABI (THAILAND) LTD., Compare to Nearest Gemcitabine Importers?
Buyers ranked immediately above and below #14 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 9 | PFIZER SERVICE COMPANY BV | HONG KONG | $750.0K | 15 | $50.0K |
| 12 | FARMA VISION IMP E EXP DE MEDICAMEN | BRAZIL | $750.0K | 15 | $50.0K |
| 14 | FRESENIUS KABI (THAILAND) LTD., ★ | THAILAND | $704.8K | 21 | $33.6K |
| 16 | APL SWIFT SERVICES (MALTA) LTD., | MALTA | $631.4K | 24 | $26.3K |
| 17 | FRESENIUS KABI (THAILAND) LTD ★ | THAILAND | $580.0K | 13 | $44.6K |
FRESENIUS KABI (THAILAND) LTD., ranks #14 among 676 Gemcitabine importers from India. Average shipment value of $33.6K compared to the market average of $29.2K. The closest competitors by value are PFIZER SERVICE COMPANY BV and FARMA VISION IMP E EXP DE MEDICAMEN.
Where Does FRESENIUS KABI (THAILAND) LTD., Import Gemcitabine To?
Destination countries from 21 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| THAILAND | $630.4K | 21 | 100.0% |
FRESENIUS KABI (THAILAND) LTD., imports Gemcitabine to 1 country. The primary destination is THAILAND receiving 100.0% of shipments worth $630.4K.
What Gemcitabine Formulations Does FRESENIUS KABI (THAILAND) LTD., Import?
| Formulation | Value | Shipments |
|---|---|---|
| GEMITA GEMCITABINE USP INJ. 1.4GM/VI | $91.1K | 2 |
| GEMITA GEMCITABINE USP INJ. 1.4GM/VIAL | $70.4K | 2 |
| GEMITA GEMCITABINE USP INJ 200MG VIAL BATCH NO 87230050AB MFG DT 01 2023 EXP DT 12 2024 | $66.2K | 2 |
| GEMITA GEMCITABINE USP INJ. 200MG/VI | $54.2K | 2 |
| GEMITA GEMCITABINEUSP INJ.1GM/VIAL BNO | $50.0K | 1 |
| GEMITA GEMCITABINE USP INJ 1GM VIAL BATCH NO 87230070AA MFG DT 02 2023 EXP DT 01 2025 | $45.8K | 2 |
| GEMITA GEMCITABINE USP INJ. 1GM/VIALBNO. 87230350AA, MANUFACTURING . DT. 07/2023, EXP. DT. 06/2025 | $43.9K | 1 |
| GEMITA GEMCITABINE USP INJ 1GM VIAL | $43.7K | 1 |
| GEMITA GEMCITABINE USP INJ 1GM VIALBATCH NO 87250137AA MFG DT 04 2025 EXP DT 03 2027 4304 VIALS | $41.5K | 1 |
| GEMITA GEMCITABINE USP INJ 1GM VIALBATCH NO 87250121AB MFG DT 04 2025 EXP DT 03 2027 4104 VIALS | $39.3K | 1 |
FRESENIUS KABI (THAILAND) LTD., imports 16 distinct Gemcitabine formulations from India. The top formulation is GEMITA GEMCITABINE USP INJ. 1.4GM/VI with 2 shipments worth $91.1K.
Who Are the Top Buyers of Gemcitabine from India and How Much Does FRESENIUS KABI (THAILAND) LTD., Import?
India exported $19.7M worth of Gemcitabine through 2,938 shipments from 248 suppliers to 125 countries, serving 676 buyers globally. FRESENIUS KABI (THAILAND) LTD., imports $630.4K of this total, accounting for 1.5% of India's Gemcitabine exports with 21 shipments from THAILAND. This is verified from 21 customs shipment records covering 16 distinct formulations.
What Is the Average Order Value for FRESENIUS KABI (THAILAND) LTD.,'s Gemcitabine Imports?
FRESENIUS KABI (THAILAND) LTD.,'s average Gemcitabine order value is $30.0K per consignment, based on 21 shipments totaling $630.4K. FRESENIUS KABI (THAILAND) LTD., is based in THAILAND and ranks #14 among all Gemcitabine importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Gemcitabine to FRESENIUS KABI (THAILAND) LTD.,?
FRESENIUS KABI (THAILAND) LTD., sources Gemcitabine from 1 verified Indian supplier: FRESENIUS KABI ONCOLOGY LIMITED ($630.4K, 100.0%). This is based on 21 customs records.
How Does FRESENIUS KABI (THAILAND) LTD., Compare to Other Gemcitabine Importers?
FRESENIUS KABI (THAILAND) LTD., ranks #14 among 676 Gemcitabine importers from India with a 1.5% market share. The top 3 importers are YUSEN LOGISTICS BENELUX BELGIUM ($5.1M), EUGIA PHARMA (MALTA) LTD, ($3.4M), PHARMACIE CENTRALE DES HOPITAUX ($2.1M). FRESENIUS KABI (THAILAND) LTD., processed 21 shipments from THAILAND.
What Other Oncology Products Does FRESENIUS KABI (THAILAND) LTD., Import?
FRESENIUS KABI (THAILAND) LTD., also imports these oncology products. Each links to the detailed product page.
About FRESENIUS KABI (THAILAND) LTD.,
FRESENIUS KABI (THAILAND) LTD., imports 7 products worth $5.0M. Beyond Gemcitabine, top products include Carboplatin, Oxaliplatin, Paclitaxel, Docetaxel, Cisplatin. View the complete FRESENIUS KABI (THAILAND) LTD., profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Gemcitabine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Gemcitabine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: FRESENIUS KABI (THAILAND) LTD., matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as FRESENIUS KABI (THAILAND) LTD.,'s capped import value divided by total capped export value for Gemcitabine across all Indian exporters.
- 5.Verified Records: This page is backed by 21 individual customs records matching FRESENIUS KABI (THAILAND) LTD., importing Gemcitabine, covering 16 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 125+ countries, 676+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Gemcitabine Import Data for FRESENIUS KABI (THAILAND) LTD.,
Access order-level details, pricing data, supplier connections, and competitive analysis for FRESENIUS KABI (THAILAND) LTD.,'s Gemcitabine imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
FRESENIUS KABI (THAILAND) LTD.,
Full Company Profile →
7 products · $5.0M total trade · 2 categories
FRESENIUS KABI (THAILAND) LTD., × Gemcitabine
Verified from customs records
Company Overview
Top Products by FRESENIUS KABI (THAILAND) LTD.,
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for FRESENIUS KABI (THAILAND) LTD.,.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Gemcitabine. For current order-level data, contact TransData Nexus.